Drug intelligence / Profile preview

3,3'-diindolylmethane

Development stage
Phase 3
Lead developer
BioResponse
Modality
Small Molecules
Administration
Oral
01

Overview

**3,3'-diindolylmethane (DIM)** is a naturally occurring compound formed in the body during the digestion of indole-3-carbinol, which is found in cruciferous vegetables such as broccoli and cabbage. It has been studied for its potential antineoplastic (anticancer) properties and as a modulator of hormone metabolism. Preclinical studies suggest that DIM exhibits anti-inflammatory, antiproliferative, and chemopreventive effects. Mechanistically, it may act by modulating estrogen metabolism—promoting the formation of less potent estrogens—and by inhibiting androgen receptor signaling pathways. DIM also inhibits certain cytochrome P450 enzymes and aromatase activity. It has been investigated in clinical trials for conditions including prostate cancer, breast cancer prevention (especially hormone-sensitive cancers), cervical dysplasia, systemic lupus erythematosus (SLE), and other hormone-related disorders[1][2][4][5].

Brand names
BioResponse-DIM
Other names
diindolylmethane3,3′-bisindolylmethane3,3′-methylenebis(1H-indole)3-(1H-indol-3-ylmethyl)-1H-indolearundinediindole methaneplant indoleindole dimer
02

Targets

ESR1 (ERα)ESR2 (ERβ)CYP1A2 (Cytochrome P450 1A2)PXR (Pregnane X receptor)CYP3A4 (Cytochrome P450 3A4)CYP19A1 (Aromatase)

Beyond the preview

Go deeper on 3,3'-diindolylmethane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3,3'-diindolylmethane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call